Cargando…

Formononetin could increase soluble-APPα secretion by up-regulating ADAM10 level

Detalles Bibliográficos
Autores principales:	Zhou, Ting, Shun, Miao, Zhou, Liang, Yang, Huan, Zhong, Kaiyin, Zhang, Ximeng, Zhang, Hui, Fan, Dongsheng, Chui, Dehua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287621/ http://dx.doi.org/10.1186/1750-1326-7-S1-O10

Ejemplares similares

Chinese herbal extract reduces Amyloid-β induced neurotoxicity through inhibiting NF-κB signaling pathway in neuronal cells
por: Wu, Xuehua, et al.
Publicado: (2012)

Testosterone regulates Arp2/3 expression by DNA methylation in hippocampus
por: Zhou, Liang, et al.
Publicado: (2012)

Implication of lipid metabolism disturbance and Alzheimer’s disease: focus on the lipoprotein lipase plays an important role in learning and memory function
por: Chui, Dehua, et al.
Publicado: (2012)

Upregulation of APP, ADAM10 and ADAM17 in the Denervated Mouse Dentate Gyrus
por: Del Turco, Domenico, et al.
Publicado: (2014)

Novel role of APP cleavage by ADAM10 for breast cancer metastasis
por: Wozniak, Justyna, et al.
Publicado: (2018)

An Alternative Pathway for Formononetin Biosynthesis in Pueraria lobata
por: Li, Jia, et al.
Publicado: (2016)

Formononetin promotes angiogenesis through the estrogen receptor alpha-enhanced ROCK pathway
por: Li, Shang, et al.
Publicado: (2015)

Formononetin: A Pathway to Protect Neurons
por: Ma, Xiaoyu, et al.
Publicado: (2022)

Parent-Metabolite Pharmacokinetic Modeling of Formononetin and Its Active Metabolites in Rats after Oral Administration of Formononetin Formulations
por: Kim, Ju Hee, et al.
Publicado: (2022)

Shifting the balance: soluble ADAM10 as a potential treatment for Alzheimer's disease
por: Hershkovits, Ayelet Sarah, et al.
Publicado: (2023)

Octyl Gallate Markedly Promotes Anti-Amyloidogenic Processing of APP through Estrogen Receptor-Mediated ADAM10 Activation
por: Zhang, She-Qing, et al.
Publicado: (2013)

Inhibitory effects of formononetin on the monocrotaline-induced pulmonary arterial hypertension in rats
por: Wu, Yonghui, et al.
Publicado: (2020)

Focus on Formononetin: Anticancer Potential and Molecular Targets
por: Ong, Samantha Kah Ling, et al.
Publicado: (2019)

Potential Anticancer Properties and Mechanisms of Action of Formononetin
por: Jiang, Dongjun, et al.
Publicado: (2019)

Anxiolytic effects of Formononetin in an inflammatory pain mouse model
por: Wang, Xin-shang, et al.
Publicado: (2019)

Formononetin inhibits enterovirus 71 replication by regulating COX- 2/PGE(2) expression
por: Wang, Huiqiang, et al.
Publicado: (2015)

Regulation of soluble guanylyl cyclase by phosphorylation
por: Zhou, Zongmin, et al.
Publicado: (2009)

Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice
por: Prinzen, Claudia, et al.
Publicado: (2009)

ADAM10 Releases a Soluble Form of the GPNMB/Osteoactivin Extracellular Domain with Angiogenic Properties
por: Rose, April A. N., et al.
Publicado: (2010)

Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands
por: Sahin, Umut, et al.
Publicado: (2004)

Insect-Induced Daidzein, Formononetin and Their Conjugates in Soybean Leaves
por: Murakami, Shinichiro, et al.
Publicado: (2014)

Formononetin: A Review of Its Anticancer Potentials and Mechanisms
por: Tay, Kai-Ching, et al.
Publicado: (2019)

Reduction of hyperoxic acute lung injury in mice by Formononetin
por: Chen, Yin, et al.
Publicado: (2021)

Focusing on Formononetin: Recent Perspectives for its Neuroprotective Potentials
por: Tian, Jiao, et al.
Publicado: (2022)

Formononetin, a Beer Polyphenol with Catabolic Effects on Chondrocytes
por: Guillán-Fresco, María, et al.
Publicado: (2023)

LRP1 shedding in human brain: roles of ADAM10 and ADAM17
por: Liu, Qiang, et al.
Publicado: (2009)

ADAM10 and ADAM17: New Players in Trastuzumab Resistance
por: Duffy, Michael J., et al.
Publicado: (2014)

ADAM10 and ADAM17—Novel Players in Retinoblastoma Carcinogenesis
por: Van Meenen, Dario, et al.
Publicado: (2022)

Anti-Colorectal Cancer Mechanisms of Formononetin Identified by Network Pharmacological Approach
por: Zhang, Lei, et al.
Publicado: (2019)

The metalloprotease ADAM10 generates soluble interleukin-2 receptor alpha (sCD25) in vivo
por: Kirschke, Sophia, et al.
Publicado: (2022)

Assessment of ADAM17 and ADAM10 proteins with CXCL10 and thyroid autoimmunity in vitiligo pathogenesis
por: Kılıc, Sevilay, et al.
Publicado: (2022)

Role of ADAM10 and ADAM17 in Regulating CD137 Function
por: Seidel, Jana, et al.
Publicado: (2021)

7-Ethoxy-4′-methoxyisoflavone (monoethylformononetin)
por: Wang, Qiu-Ya
Publicado: (2008)

Coronavirus neuropathogenesis: could SARS be the tip of the iceberg?
por: Talbot, Pierre J, et al.
Publicado: (2008)

Anti-cancer targets and molecular mechanisms of formononetin in treating osteosarcoma based on network pharmacology
por: Chen, Lizhi, et al.
Publicado: (2023)

Formononetin regulates endothelial nitric oxide synthase to protect vascular endothelium in deep vein thrombosis rats
por: Zhou, Zhongxiao, et al.
Publicado: (2022)

Role of APP in neuronal function
por: Zheng, Hui
Publicado: (2013)

Influence of Anoctamin-4 and -9 on ADAM10 and ADAM17 Sheddase Function
por: Leitzke, Sinje, et al.
Publicado: (2022)

Role of ADAM10 and ADAM17 in the Regulation of Keratinocyte Adhesion in Pemphigus Vulgaris
por: Kugelmann, Daniela, et al.
Publicado: (2022)

Formononetin induces vasorelaxation in rat thoracic aorta via regulation of the PI3K/PTEN/Akt signaling pathway
por: Li, Teng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cqebaepe2iq9da1nma9kvkbp83